Gallium-68 (Ga-68) FAPI-PET/CT imaging, an experimental technique for detecting cancer, may help improve outcomes for patients undergoing radiation therapy, according to a recent analysis by German researchers. The study found that Ga-68 FAPI-PET/CT imaging detected malignant lesions not visible on standard imaging in over half of the patients and led to changes in management and more accurate therapy planning. The technique utilizes radiolabeled fibroblast activation protein (FAPI) tracers to target stromal fibroblast cells in epithelial cancers. The study evaluated 226 patients with various solid tumors and found that Ga-68 FAPI-PET/CT imaging had a significant impact on TNM staging and clinical management, particularly in lung cancer, pancreatic cancer, and head and neck tumors. The researchers concluded that the study provides a basis for future randomized trials to further assess the value of Ga-68 FAPI-PET/CT imaging.
Tue, 12 Sep 2023 07:05:12 GMT | AuntMinnie